Sabatini Brent 4
4 · Vir Biotechnology, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Sabatini Brent
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-02-13$9.15/sh−1,562$14,291→ 28,189 total
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program.